United Therapeutics Buys Lexington Clean Rooms Facility
A publicly traded life science company acquired a clean rooms facility in Lexington from Brammer Bio for $21.5 million.
BXP Submits Redesign of Kendall Square Development
BXP unveiled proposed changes to the next phase of its MXD District in Cambridge’s Kendall Square, including an option for two smaller commercial buildings that reflect “evolving market conditions.”
Court Rules Biogen Not to Blame for Subtenants’ Woes
A Suffolk Superior Court judge dismissed a biomanufacturing company’s lawsuit that claimed disruption caused by a Kendall Square development caused it to lose virtually all of its long-term contracts.
BXP, Tenant in Lawsuit Tied to Three-Tower Kendall Project
A contract biomanufacturer says a planned redevelopment by Boston Properties could disrupt its current and future business if the Kendall Square property where it has invested $100 million since 2017 is demolished.
